{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:01:18Z","timestamp":1790359278556,"version":"4.1.0"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>The link between insulin resistance (IR) and hepatocellular carcinoma (HCC), especially in relation to HCV genotype-3 infection, is still poorly understood. In South Asian countries and among the peoples of the United States, this problem remains a major public health concern. According to previous studies, metabolic and viral interactomes have not been analyzed together, and hence this is a limitation of the study. This cross-sectional observational study involved 110 people, categorized into control (n=20), chronic hepatitis C (CHC) (n=45), and hepatocellular carcinoma (HCC) (n=45) groups. Clinical, biochemical, and metabolic parameters-HOMA-IR and HbA1c-were measured. The appropriate statistical tests were used for group comparisons. We performed molecular docking to investigate the interaction between the HCV genotype-3 core protein and human IRS-1 using ClusPro. HCC was independently associated with stage III-V fibrosis (AOR: 24.18), elevated HOMA-IR &gt;4, a key indicator of insulin resistance (AOR: 3.53), and AFP &gt;10 ng\/mL (AOR: 3.71). Moreover, HbA1c &gt;7% greater GGT and low albumin level were significantly higher in HCC group (P&lt;0.05). Obese patients had higher IR markers, but CHC-to-HCC progression depended more on combined fibrosis and metabolic dysregulation than obesity alone. Docking analysis, there was a strong hydrophobic and electrostatic interaction between HCV core protein and IRS-1, with a binding energy of -1196.0 kcal\/mol, indicating a strong and stable interaction between the two proteins. According to this study, it is possible that the presence of insulin resistance, advanced fibrosis, and viral persistence may interact biochemically and molecularly to contribute to hepatocellular carcinoma in cases of HCV genotype-3 infection.<\/jats:p>","DOI":"10.1371\/journal.pone.0358858","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:37:12Z","timestamp":1790357832000},"page":"e0358858","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of insulin resistance in the development of hepatocellular carcinoma with computational analysis of IRS-1 interaction with HCV genotype 3 core protein"],"prefix":"10.1371","volume":"21","author":[{"given":"Dr","family":"Tufael","sequence":"first","affiliation":[{"name":"Parul University","place":["Vadodara, Gujarat, India"],"department":["Department of Biochemistry"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3115-7855","authenticated-orcid":true,"given":"Mohd Hasan","family":"Mujahid","sequence":"additional","affiliation":[{"name":"Indian Institute of Technology Roorkee","place":["Uttarakhand, India"],"department":["Department of Polymer and Process Engineering"]},{"name":"Maulana Azad National Urdu University","place":["Hyderabad, Telangana, India"],"department":["Botany Section, School of Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Most Farhana","family":"Akter","sequence":"additional","affiliation":[{"name":"University of Development Alternative","place":["Dhaka, Bangladesh"],"department":["Department of Pharmacy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahsin","family":"Salam","sequence":"additional","affiliation":[{"name":"United Medical College Hospital","place":["Dhaka, Bangladesh"],"department":["Internal Medicine and Critical Care Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Abu Bakar","family":"Siddique","sequence":"additional","affiliation":[{"name":"St John\u2019s University","place":["New York, United States of America"],"department":["Department of Biological Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaniz Fatima","family":"Bari","sequence":"additional","affiliation":[{"name":"Shaphena Women\u2019s Dental College","place":["Dhaka, Bangladesh"],"department":["Department of Biochemistry"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim","family":"Debnath","sequence":"additional","affiliation":[{"name":"Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida","place":["Orlando, Florida, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil Deb","family":"Nath","sequence":"additional","affiliation":[{"name":"The City University of New York","place":["New York, United States of America"],"department":["Department of Biology"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"03","key":"pone.0358858.ref001","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-0043-1771182","article-title":"Molecular epidemiology of HCV RNA genotype-3 in Dhaka city, Bangladesh.","volume":"10","author":"MA Rahman","year":"2023","journal-title":"Glob Med Genet"},{"issue":"1","key":"pone.0358858.ref002","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.27095","article-title":"HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV","volume":"60","author":"F Kanwal","year":"2014","journal-title":"Hepatology"},{"issue":"11","key":"pone.0358858.ref003","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.70049","article-title":"Distribution and inflammatory potential of hepatitis C virus genotypes in the United States, 2011\u20132020","volume":"8","author":"K Gnanapandithan","year":"2024","journal-title":"JGH Open"},{"key":"pone.0358858.ref004","doi-asserted-by":"crossref","first-page":"1510939","DOI":"10.3389\/fcimb.2025.1510939","article-title":"Genotype 3 is linked to worse liver disease progression in hepatitis C patients even after SVR following DAA therapy","volume":"15","author":"X Ran","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"pone.0358858.ref005","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1038\/s41598-022-09588-w","article-title":"Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis","volume":"12","author":"DA Sheridan","year":"2022","journal-title":"Sci Rep"},{"issue":"3","key":"pone.0358858.ref006","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.22392","article-title":"Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C","author":"IHY Cua","year":"2008","journal-title":"Hepatology"},{"issue":"13","key":"pone.0358858.ref007","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3748\/wjg.v27.i13.1267","article-title":"Metabolic complications of hepatitis C virus infection","volume":"27","author":"R Chaudhari","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"4","key":"pone.0358858.ref008","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.62347\/EQIR8735","article-title":"Effect of metabolic dysfunction on the risk of liver-related events in patients cured of hepatitis C virus","volume":"14","author":"W-F Hsu","year":"2024","journal-title":"Am J Cancer Res"},{"issue":"1","key":"pone.0358858.ref009","article-title":"Insulin receptor substrate-1 G972R single nucleotide polymorphism in Egyptian patients with chronic hepatitis C virus infection and type 2 diabetes mellitus","volume":"11","author":"RN Bedair","year":"2021","journal-title":"Egypt Liver Journal"},{"key":"pone.0358858.ref010","doi-asserted-by":"crossref","first-page":"9927410","DOI":"10.1155\/av\/9927410","article-title":"Hepatitis C in North Africa: a comprehensive review of epidemiology, genotypic diversity, and hepatocellular carcinoma","volume":"2025","author":"S Boukaira","year":"2025","journal-title":"Adv Virol"},{"key":"pone.0358858.ref011","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.2147\/IDR.S337647","article-title":"Genetic variability in patients with HCV-related hepatocellular carcinoma","volume":"14","author":"M Pisaturo","year":"2021","journal-title":"Infect Drug Resist"},{"issue":"1","key":"pone.0358858.ref012","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s13063-016-1454-6","article-title":"Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial","volume":"17","author":"MA Doyle","year":"2016","journal-title":"Trials"},{"issue":"7","key":"pone.0358858.ref013","doi-asserted-by":"crossref","DOI":"10.1111\/jvh.70032","article-title":"Leading role of sofosbuvir\/daclatasvir in achieving hepatitis C elimination in Egypt","volume":"32","author":"T Elbaz","year":"2025","journal-title":"J Viral Hepat"},{"issue":"1","key":"pone.0358858.ref014","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/jgh.70160","article-title":"Predictive value of serum mac-2 binding protein glycosylation isomer for hepatic fibrosis in hepatitis C virus-infected patients with metabolic dysfunction-associated steatotic liver disease","volume":"41","author":"Y-C Chen","year":"2026","journal-title":"J Gastroenterol Hepatol"},{"issue":"21","key":"pone.0358858.ref015","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71330","article-title":"Recent advancements in known and emerging risk factors of hepatocellular carcinoma","volume":"14","author":"MM Hussain","year":"2025","journal-title":"Cancer Med"},{"key":"pone.0358858.ref016","article-title":"In silico screening, pharmacokinetic, DFT, and dynamics simulation study of ant-hepatitis C virus compounds as potential NS5B polymerase inhibitors","author":"S Ejeh","year":"2024","journal-title":"Sci Afr"},{"key":"pone.0358858.ref017","doi-asserted-by":"crossref","first-page":"1498069","DOI":"10.3389\/fmicb.2024.1498069","article-title":"In silico analysis of the effect of HCV genotype-specific polymorphisms in Core, NS3, NS5A, and NS5B proteins on T-cell epitope processing and presentation","volume":"15","author":"S Baig","year":"2025","journal-title":"Front Microbiol"},{"issue":"18","key":"pone.0358858.ref018","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37990","article-title":"Chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease: Metabolic risk factors are key drivers of hepatocellular carcinoma","volume":"10","author":"G Adali","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"pone.0358858.ref019","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13099-025-00761-w","article-title":"Gut microbiome dysbiosis in hepatocellular carcinoma patients with persistent HCV viremia versus viral clearance: a cross-sectional study","volume":"17","author":"HR Hashem","year":"2025","journal-title":"Gut Pathog"},{"issue":"5","key":"pone.0358858.ref020","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/apt.17862","article-title":"Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection","volume":"59","author":"N-L Kang","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"pone.0358858.ref021","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1365-2036.2011.04618.x","article-title":"Systematic review: the presenting international normalised ratio (INR) as a predictor of outcome in patients with upper nonvariceal gastrointestinal bleeding","volume":"33","author":"A Shingina","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"pone.0358858.ref022","doi-asserted-by":"crossref","first-page":"2554926","DOI":"10.1080\/07853890.2025.2554926","article-title":"Impact of thrombocytopenia and coagulopathy on partial hepatectomy and Hassab\u2019s operation in patients with cirrhosis: a multicenter retrospective cohort study","volume":"57","author":"Q Yang","year":"2025","journal-title":"Ann Med"},{"issue":"16","key":"pone.0358858.ref023","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.3390\/app14167096","article-title":"Association between Resting Heart Rate and Homeostatic Model Assessment of Insulin Resistance in South Korean Adults","volume":"14","author":"A-S Heo","year":"2024","journal-title":"Applied Sciences"},{"key":"pone.0358858.ref024","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2147\/JHC.S499966","article-title":"The diagnostic performance of AFP, AFP-L3, DCP, CA199, and their combination for primary liver cancer","volume":"12","author":"Y Liu","year":"2025","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"pone.0358858.ref025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/1740028032000131396","article-title":"Thirty years of bioethics: the helsinki declaration 1964-2003","author":"P Riis","year":"2003","journal-title":"New Rev Bioeth"},{"issue":"10","key":"pone.0358858.ref026","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/1348-0421.13023","article-title":"Hepatitis C virus, insulin resistance, and diabetes: a review","volume":"66","author":"N Alzahrani","year":"2022","journal-title":"Microbiol Immunol"},{"issue":"7","key":"pone.0358858.ref027","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/1521654031000138569","article-title":"IRS-1 regulation in health and disease","volume":"55","author":"C Schmitz-Peiffer","year":"2003","journal-title":"IUBMB Life"},{"issue":"5","key":"pone.0358858.ref028","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0002-9440(10)63408-6","article-title":"Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3","volume":"165","author":"T Kawaguchi","year":"2004","journal-title":"Am J Pathol"},{"issue":"10","key":"pone.0358858.ref029","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.3390\/biomedicines12102400","article-title":"Hepatitis C infection is not a cardiovascular risk factor in young adults","volume":"12","author":"P Rajewski","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"pone.0358858.ref030","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/1743-422X-8-496","article-title":"Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma","volume":"8","author":"AA Mohamed","year":"2011","journal-title":"Virol J"},{"issue":"5","key":"pone.0358858.ref031","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/jgh.13647","article-title":"Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients","volume":"32","author":"JH Kim","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"pone.0358858.ref032","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4239\/wjd.v5.i1.52","article-title":"Hepatitis C virus infection and insulin resistance","volume":"5","author":"SK Bose","year":"2014","journal-title":"World J Diabetes"},{"issue":"24","key":"pone.0358858.ref033","article-title":"Inflammatory effects and regulatory mechanisms of chitinase-3-like-1 in multiple human body systems: a comprehensive review","volume":"25","author":"D Liu","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"3","key":"pone.0358858.ref034","doi-asserted-by":"crossref","DOI":"10.5501\/wjv.v14.i3.108754","article-title":"Hepatitis C virus-associated cardiomyopathy: a review of pathogenesis","volume":"14","author":"IS Bharaj","year":"2025","journal-title":"World J Virol"},{"issue":"5","key":"pone.0358858.ref035","article-title":"Combined biomarkers for early diagnosis of hepatocellular carcinoma","volume":"8","author":"Tufael","year":"2024","journal-title":"J Angiotherapy"},{"issue":"1","key":"pone.0358858.ref036","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12985-015-0241-4","article-title":"Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner","volume":"12","author":"T Gao","year":"2015","journal-title":"Virol J"},{"key":"pone.0358858.ref037","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-230X-12-74","article-title":"Hepatitis C virus E2 protein involve in insulin resistance through an impairment of Akt\/PKB and GSK3\u03b2 signaling in hepatocytes","volume":"12","author":"M-J Hsieh","year":"2012","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"pone.0358858.ref038","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s12876-025-04109-1","article-title":"Metabolic dysfunction, cirrhosis, and HCV genotype 3a drive type 2 diabetes risk in chronic hepatitis C: a Southern Chinese cohort study","volume":"25","author":"Z Li","year":"2025","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"pone.0358858.ref039","doi-asserted-by":"crossref","DOI":"10.1186\/s43066-021-00129-0","article-title":"Evaluation of HCV-related liver fibrosis post-successful DAA therapy","volume":"11","author":"N Ehsan","year":"2021","journal-title":"Egypt Liver Journal"},{"issue":"7","key":"pone.0358858.ref040","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.2337\/dc18-2578","article-title":"Use of plasma fragments of propeptides of Type III, V, and VI procollagen for the detection of liver fibrosis in Type 2 diabetes","volume":"42","author":"F Bril","year":"2019","journal-title":"Diabetes Care"},{"issue":"5","key":"pone.0358858.ref041","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/jgh.12313","article-title":"Chronic hepatitis C infection is associated with insulin resistance and lipid profiles","volume":"30","author":"C-Y Dai","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"pone.0358858.ref042","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1478-3231.2007.01626.x","article-title":"High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C","volume":"28","author":"C Hsu","year":"2008","journal-title":"Liver International"},{"key":"pone.0358858.ref043","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/1751-2980.13103","article-title":"Effects of direct\u2010acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: a real\u2010life Italian experience","volume":"23","author":"A Dalbeni","year":"2022","journal-title":"J Dig Dis"},{"issue":"2","key":"pone.0358858.ref044","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s12072-012-9412-1","article-title":"Insulin resistance, inflammation, and nonalcoholic fatty liver disease in non-obese adults without metabolic syndrome components","volume":"7","author":"S Kim","year":"2013","journal-title":"Hepatol Int"},{"issue":"4","key":"pone.0358858.ref045","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10238-021-00773-1","article-title":"The impact of HCV eradication on hyperglycemia, insulin resistance, cytokine production, and insulin receptor substrate-1 and 2 expression in patients with HCV infection","volume":"22","author":"B Mahmoud","year":"2021","journal-title":"Clin Exp Med"},{"issue":"3","key":"pone.0358858.ref046","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/nu17030594","article-title":"Thyroid stimulatory activity of houttuynia cordata thunb. ethanolic extract in 6-propyl-thiouracil-induced hypothyroid and STZ induced diabetes rats: in vivo and in silico studies","volume":"17","author":"SS Rahman","year":"2025","journal-title":"Nutrients"},{"issue":"2","key":"pone.0358858.ref047","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/molecules23020258","article-title":"Action of phytochemicals on insulin signaling pathways accelerating glucose transporter (GLUT4) protein translocation","volume":"23","author":"ASM Sayem","year":"2018","journal-title":"Molecules"},{"issue":"4","key":"pone.0358858.ref048","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s13205-024-03955-2","article-title":"Ab initio modeling of human IRS1 protein to find novel target to dock with drug MH to mitigate T2DM diabetes by insulin signaling","volume":"14","author":"RK Singh","year":"2024","journal-title":"3 Biotech"},{"key":"pone.0358858.ref049","doi-asserted-by":"crossref","first-page":"124917","DOI":"10.1016\/j.ijbiomac.2023.124917","article-title":"Glyphosate potentiates insulin resistance in skeletal muscle through the modulation of IRS-1\/PI3K\/Akt mediated mechanisms: an in vivo and in silico analysis","volume":"242","author":"S Jayaraman","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"pone.0358858.ref050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.14744\/hf.2022.2022.0037","article-title":"Incidental combined hepatocellular-cholangiocarcinoma in liver transplant patients: Does it have a worse prognosis?.","author":"E Anilir","year":"2023","journal-title":"Hepatology Forum"},{"issue":"3","key":"pone.0358858.ref051","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/diagnostics12030665","article-title":"Dynamic change of albumin-bilirubin score is good predictive parameter for prognosis in chronic hepatitis C-hepatocellular carcinoma patients receiving transarterial chemoembolization","volume":"12","author":"P-T Lin","year":"2022","journal-title":"Diagnostics"},{"issue":"1","key":"pone.0358858.ref052","doi-asserted-by":"crossref","DOI":"10.70818\/apjcr.2024.v01i01.07","article-title":"Hepatocellular carcinoma in a 55-year-old with chronic hepatitis B: a case report on diagnosis and management","volume":"1","author":"Tufael","year":"2024","journal-title":"Asia Pacific J Cancer Res"},{"issue":"9","key":"pone.0358858.ref053","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41575-024-00936-x","article-title":"Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement","volume":"21","author":"BP Lee","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"36","key":"pone.0358858.ref054","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.3748\/wjg.v17.i36.4055","article-title":"Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis","volume":"17","author":"M Basaranoglu","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"4","key":"pone.0358858.ref055","article-title":"Diagnostic efficacy of tumor markers AFP, CA19-9, and CEA in hepatocellular carcinoma patients","volume":"8","author":"Tufael","year":"2024","journal-title":"J Angiother"},{"issue":"20","key":"pone.0358858.ref056","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011137","article-title":"Insulin resistance and cancer: in search for a causal link","volume":"22","author":"E Chiefari","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0358858.ref057","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2009.02.053","article-title":"A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention","volume":"286","author":"CP Wild","year":"2009","journal-title":"Cancer Lett"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0358858","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:37:20Z","timestamp":1790357840000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0358858"}},"subtitle":[],"editor":[{"given":"Yury E","family":"Khudyakov","sequence":"first","affiliation":[{"name":"Centers for Disease Control and Prevention","place":["UNITED STATES OF AMERICA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":57,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0358858","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]}}}